A 6-year-old Chinese girl died last year after receiving an experimental gene therapy to correct a non-life-threatening ...
Morning Overview on MSN
A baby born with a lethal genetic disorder is walking and talking after a one-of-a-kind CRISPR fix
An infant named KJ Muldoon, born with a severe and typically fatal genetic disorder called CPS1 deficiency, is now walking and talking after receiving a one-of-a-kind, patient-specific gene-editing ...
Morning Overview on MSN
A CRISPR therapy for toddlers just cleared the FDA, putting a possible sickle cell cure in reach
Children as young as two with sickle cell disease can now receive a one-time CRISPR-based gene therapy after the FDA issued a ...
CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ...
Add Yahoo as a preferred source to see more of our stories on Google. Stanford researchers have developed CRISPR-GPT, an AI-powered copilot that guides gene-editing experiments. (CREDIT: Shutterstock) ...
A pivotal medical milestone has been reached. For the first time ever, researchers have used a personalized CRISPR-based gene therapy to treat an infant’s rare and life-threatening illness. Doctors at ...
CRISPR Therapeutics' founders essentially found a way of repairing damaged DNA with a corrected genetic sequence. It was the first company to ever win the FDA's approval for a gene-editing drug, in ...
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
CHICAGO (Reuters) -A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half in four people taking the ...
Developing a gene therapy typically takes years, but when Baby KJ was diagnosed with a deadly genetic condition, scientists had only months. What followed was a successful collaboration among ...
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results